跳至主要内容
临床试验/ACTRN12618001749291
ACTRN12618001749291尚未招募未知

The hemodynamic and physiological effects of rapid versus slow fluid bolus therapy with 4% albumin in ICU patients with severe sepsis or septic shock

Taeseon Shin0 个研究点目标入组 68 人开始时间: 2018年10月24日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Admitted to ICU
  • Age 18 years or older
  • Meeting clinical criteria for fluid bolus administration (one of the following):
  • oMAP <65mmHg
  • oHR >100bpm
  • oUrine output <0.5ml/kg/hr
  • oLactate levels of >3mmol/dL
  • oCardiac index <2.5L/min/m2

排除标准

  • Evidence of fluid overload or acute pulmonary edema
  • Patient has contraindications to receiving albumin (e.g., allergic reaction or Jenovah’s Witness)
  • Active bleeding requiring transfusion
  • Haemoglobin level <70g/L
  • Patients in whom death is considered imminent (within 24 hours)
  • Receiving continuous renal replacement therapy (CRRT) or hemodialysis
  • Expected discharge from ICU during 2 hour monitoring period
  • Inability to give consent or refusing to consent
  • Inability to obtain satisfactory echocardiographic images for cardiac output measurement

研究者

发起方
Taeseon Shin

相似试验